Drugs / CJH1
last change Sep 2013 re-read 3 minutes ago

CJH1

also known as CLR4001
Developed for
Parkinson disease
Investigated by
Alexandra Marine and General Hospital

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01684475 Sep 2012 → Sep 2013 Parkinson disease Alexandra Marine and General Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CJH1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01684475 ↗
Known as CLR4001 “CJH1 (CLR4001)” NCT01684475 ↗